Cyclin D1 overexpression and poor clinical outcomes in Taiwanese oral cavity squamous cell carcinoma

World Journal of Surgical Oncology

Volumn 10, Issue , 2012, Pages

  Huang, Shiang Fu ^a   Cheng, Sou De ^b   Chuang, Wen Yu ^a   Chen, I How ^a   Liao, Chun Ta ^a   Wang, Hung Ming ^a   Hsieh, Ling Ling ^b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Cyclin D1; Lymph node metastasis; Oral squamous cell carcinoma

Indexed keywords

CYCLIN D1; CCND1 PROTEIN, HUMAN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER CELL; CANCER STAGING; CANCER SURVIVAL; CELL DIFFERENTIATION; DISEASE ASSOCIATION; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; ORAL CAVITY SQUAMOUS CELL CARCINOMA; OUTCOME ASSESSMENT; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TAIWAN; ARECA; ENZYME IMMUNOASSAY; FEMALE; FOLLOW UP; METABOLISM; METASTASIS; MIDDLE AGED; MORTALITY; MOUTH TUMOR; PATHOLOGY; PROGNOSIS; SURVIVAL RATE; TUMOR RECURRENCE;

ADULT; AGED; ARECA; CARCINOMA, SQUAMOUS CELL; CYCLIN D1; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 84856944664     PISSN: None     EISSN: 14777819     Source Type: Journal    
DOI: 10.1186/1477-7819-10-40     Document Type: Article

References (25)

1. Department-of-Health Cancer registry annual report in Taiwan Area, 2009. Taipei: The Executive Yuan, Taiwan ROC 2009, Department-of-Health.
2. Liao CT, Wang HM, Ng SH, Yen TC, Lee LY, Hsueh C, Wei FC, Chen IH, Kang CJ, Huang SF, Chang JT. Good tumor control and survivals of squamous cell carcinoma of buccal mucosa treated with radical surgery with or without neck dissection in Taiwan. Oral Oncol 2006, 42:800-809. 10.1016/j.oraloncology.2005.11.020, 16458038.
3. Pestell RG, Albanese C, Reutens AT, Segall JE, Lee RJ, Arnold A. The cyclins and cyclin-dependent kinase inhibitors in hormonal regulation of proliferation and differentiation. Endocr Rev 1999, 20:501-534. 10.1210/er.20.4.501, 10453356.
4. Hinds PW, Dowdy SF, Eaton EN, Arnold A, Weinberg RA. Function of a human cyclin gene as an oncogene. Proc Natl Acad Sci USA 1994, 91:709-713. 10.1073/pnas.91.2.709, 43018, 8290586.
5. Jiang W, Kahn SM, Zhou P, Zhang YJ, Cacace AM, Infante AS, Doi S, Santella RM, Weinstein IB. Overexpression of cyclin D1 in rat fibroblasts causes abnormalities in growth control, cell cycle progression and gene expression. Oncogene 1993, 8:3447-3457.
6. Michalides R, van Veelen N, Hart A, Loftus B, Wientjens E, Balm A. Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck. Cancer Res 1995, 55:975-978.
7. Bova RJ, Quinn DI, Nankervis JS, Cole IE, Sheridan BF, Jensen MJ, Morgan GJ, Hughes CJ, Sutherland RL. Cyclin D1 and p16INK4A expression predict reduced survival in carcinoma of the anterior tongue. Clin Cancer Res 1999, 5:2810-2819.
8. Kaminagakura E, Werneck da Cunha I, Soares FA, Nishimoto IN, Kowalski LP. CCND1 amplification and protein overexpression in oral squamous cell carcinoma of young patients. Head Neck 2011, 33:1413-1419. 10.1002/hed.21618, 21254295.
9. Kyomoto R, Kumazawa H, Toda Y, Sakaida N, Okamura A, Iwanaga M, Shintaku M, Yamashita T, Hiai H, Fukumoto M. Cyclin-D1-gene amplification is a more potent prognostic factor than its protein over-expression in human head-and-neck squamous-cell carcinoma. Int J Cancer 1997, 74:576-581. 10.1002/(SICI)1097-0215(19971219)74:6<576::AID-IJC3>3.0.CO;2-R, 9421351.
10. Association of directors of anatomic surgical pathology. Recommendations for the reporting of specimens containing oral cavity and oropharynx neoplasms. Mod Pathol 2000, 13:1038-1041.
11. Huang SF, Chuang WY, Chen IH, Liao CT, Wang HM, Hsieh LL. EGFR protein overexpression and mutation in areca quid-associated oral cavity squamous cell carcinoma in Taiwan. Head Neck 2009, 31:1068-1077. 10.1002/hed.21067, 19360742.
12. Wang L, Liu T, Nishioka M, Aguirre RL, Win SS, Okada N. Activation of ERK1/2 and cyclin D1 expression in oral tongue squamous cell carcinomas: relationship between clinicopathological appearances and cell proliferation. Oral Oncol 2006, 42:625-631. 10.1016/j.oraloncology.2005.11.002, 16483832.
13. Miyamoto R, Uzawa N, Nagaoka S, Hirata Y, Amagasa T. Prognostic significance of cyclin D1 amplification and overexpression in oral squamous cell carcinomas. Oral Oncol 2003, 39:610-618. 10.1016/S1368-8375(03)00048-4, 12798405.
14. Massano J, Regateiro FS, Januario G, Ferreira A. Oral squamous cell carcinoma: review of prognostic and predictive factors. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006, 102:67-76. 10.1016/j.tripleo.2005.07.038, 16831675.
15. Gimenez-Conti IB, Collet AM, Lanfranchi H, Itoiz ME, Luna M, Xu HJ, Hu SX, Benedict WF, Conti CJ. p53, Rb, and cyclin D1 expression in human oral verrucous carcinomas. Cancer 1996, 78:17-23. 10.1002/(SICI)1097-0142(19960701)78:1<17::AID-CNCR4>3.0.CO;2-E, 8646714.
16. Kuo MY, Lin CY, Hahn LJ, Cheng SJ, Chiang CP. Expression of cyclin D1 is correlated with poor prognosis in patients with areca quid chewing-related oral squamous cell carcinomas in Taiwan. J Oral Pathol Med 1999, 28:165-169.
17. Mineta H, Miura K, Takebayashi S, Ueda Y, Misawa K, Harada H, Wennerberg J, Dictor M. Cyclin D1 overexpression correlates with poor prognosis in patients with tongue squamous cell carcinoma. Oral Oncol 2000, 36:194-198. 10.1016/S1368-8375(99)00078-0, 10745172.
18. Lam KY, Ng IO, Yuen AP, Kwong DL, Wei W. Cyclin D1 expression in oral squamous cell carcinomas: clinicopathological relevance and correlation with p53 expression. J Oral Pathol Med 2000, 29:167-172. 10.1034/j.1600-0714.2000.290404.x, 10766394.
19. Carlos de Vicente J, Herrero-Zapatero A, Fresno MF, Lopez-Arranz JS. Expression of cyclin D1 and Ki-67 in squamous cell carcinoma of the oral cavity: clinicopathological and prognostic significance. Oral Oncol 2002, 38:301-308. 10.1016/S1368-8375(01)00060-4, 11978554.
20. Reis-Filho JS, Savage K, Lambros MB, James M, Steele D, Jones RL, Dowsett M. Cyclin D1 protein overexpression and CCND1 amplification in breast carcinomas: an immunohistochemical and chromogenic in situ hybridisation analysis. Mod Pathol 2006, 19:999-1009. 10.1038/modpathol.3800621, 16648863.
21. Gown AM, Goldstein LC, Barry TS, Kussick SJ, Kandalaft PL, Kim PM, Tse CC. High concordance between immunohistochemistry and fluorescence in situ hybridization testing for HER2 status in breast cancer requires a normalized IHC scoring system. Mod Pathol 2008, 21:1271-1277. 10.1038/modpathol.2008.83, 18487992.
22. Marx J. How cells cycle toward cancer. Science 1994, 263:319-321. 10.1126/science.8278804, 8278804.
23. Capaccio P, Pruneri G, Carboni N, Pagliari AV, Quatela M, Cesana BM, Pignataro L. Cyclin D1 expression is predictive of occult metastases in head and neck cancer patients with clinically negative cervical lymph nodes. Head Neck 2000, 22:234-240. 10.1002/(SICI)1097-0347(200005)22:3<234::AID-HED5>3.0.CO;2-3, 10748446.
24. Skapek SX, Rhee J, Spicer DB, Lassar AB. Inhibition of myogenic differentiation in proliferating myoblasts by cyclin D1-dependent kinase. Science 1995, 267:1022-1024. 10.1126/science.7863328, 7863328.
25. Chandrasekaran C, Coopersmith CM, Gordon JI. Use of normal and transgenic mice to examine the relationship between terminal differentiation of intestinal epithelial cells and accumulation of their cell cycle regulators. J Biol Chem 1996, 271:28414-28421. 10.1074/jbc.271.45.28414, 8910466.